Key result
Treatment with AdNDRG2 ameliorated myocardial remodeling, reduced apoptosis, and improved heart function in heart failure rats via inhibition of the TGF-β1/Smad pathway.
Why the study?
This study aims to explore the effect of NDRG2-mediated TGF-β1/Smad pathway in heart failure rats.
Does AdNDRG2 treatment improve heart function and myocardial remodeling in heart failure rats?
Does AdNDRG2 treatment improve heart function and myocardial remodeling in heart failure rats?
NDRG2 overexpression improves cardiac function and attenuates myocardial remodeling and apoptosis in heart failure rats via inhibition of the TGF-β1/Smad pathway.
This study aims to explore the effect of NDRG2 (N-myc downstream regulated gene 2)-mediated Transforming growth factor-beta 1 (TGF-β1)/ Sma- and Mad-related protein (Smad) pathway in heart failure (HF) rats. HF rat models were established and treated with AdEGFP (adenovirus encoding enhanced green fluorescent protein) or AdNDRG2 (adenovirus encoding NDRG2). The echocardiography and hemodynamic parameters were detected, and the infarct size was calculated via 2,3,5-triphenyltetrazolium chloride (TTC) staining. Masson staining was performed to observe the collagen volume fraction (CVF), quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to detect the expression of Collagen I (Col-I) and Collagen III (Col-III), and Transferase (TdT)-mediated D-UTP-biotin nick end labeling (TUNEL) staining to evaluate the apoptosis. Rats in the Model group presented with the decreases in left ventricular ejection fraction (LVEF), left ventricular shortening fraction (LVFS), left ventricular systolic pressure (LVSP) and maximal/minimum rate of left ventricular pressure (±dp/dt max), and significant increases in left ventricular end-diastolic pressure (LVEDP) and CVF. At the meantime, the expression of Col-I and Col-III as well as the apoptotic rate of myocardial cells was also elevated with increased infarct size in the Model group. The Model rats also had the significant reduction in the expression of NDRG2 and up-regulations of TGF-β1, p-Smad2/Smad2, p-Smad3/Smad3 and tissue inhibitor of metalloproteinases-2 (TIMP-2). However, model rats treated with AdNDRG2 had evident amelioration in aforementioned indicators. In conclusion, NDRG2 reduces the apoptosis of myocardial cells and improves the heart function and myocardial remodeling in HF rats via inhibiting the activity of TGF-β1/Smad.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2021) studied Heart failure. AdNDRG2 (adenovirus encoding NDRG2) vs. AdEGFP or untreated Model group was evaluated on Myocardial remodeling, cardiac function, and apoptosis. Treatment with AdNDRG2 ameliorated myocardial remodeling, reduced apoptosis, and improved heart function in heart failure rats via inhibition of the TGF-β1/Smad pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: